Cefepime, marketed as Maxipime, is manufactured by Bristol Meyers Squibb. A recent study of this drug has raised concerns about the increased mortality rate associated with its use. Based on this study, the FDA has begun a safety review which will not be completed for another four months. Cefepine or Maxipine is an antibioltic used for patients who have infections of the ear, chest, skin, bones, bladder of gonorrhea. For more information check the FDA website at: http://www.fda.gov/cder/drug/early_comm/cefepime.htm
For more information on this subject, please see our section on Drugs, Medical Devices and Implants.
The Legal Examiner and our Affiliate Network strive to be the place you look to for news, context, and more, wherever your life intersects with the law.